Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sporadic
amyotrophic lateral sclerosis
is an idiopathic human degenerative disease of spinal cord and brain motor neurons. Prior studies demonstrated that most patients with
amyotrophic lateral sclerosis
possess immunoglobulins that bind to purified L-type voltage-gated calcium channels, that titers of anti-voltage-gated calcium channel antibodies correlate with disease progression rates, and that
amyotrophic lateral sclerosis
patient-derived antibodies (
ALS
IgG) produce electrophysiological changes in the function of voltage-gated calcium channels. Using Western transfer immunoblots and enzyme-linked immunosorbent assays, the calcium ionophore-forming alpha 1 subunit of the voltage-gated calcium channel is now identified as the major voltage-gated calcium channel antigen to which
ALS
IgG binds. Additionally, the binding of an L-type
voltage-gated calcium channel alpha 1 subunit
-directed monoclonal antibody, which itself mimics the effects of
ALS
IgG on skeletal muscle voltage-gated calcium channel currents, is selectively prevented by preaddition of
ALS
IgG. Voltage-gated calcium channel-binding IgG from patients with Lambert-Eaton myasthenic syndrome appears to be differentiated from
ALS
IgG by the reactivity of the former to both alpha 1 and beta subunits of the calcium channel. These assays provide further evidence linking
amyotrophic lateral sclerosis
to an autoimmune process, and suggest one means to differentiate immunoglobulins from patients with
amyotrophic lateral sclerosis
from those of patients with another autoimmune disease expressing calcium channel antibodies.
...
PMID:Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. 810 94